User:gerardegzn913986

Emibetuzumab, initially known as LY2875358, represents a novel therapeutic method in oncology, specifically targeting the HGFR tyrosine protein. This humanized antibody works by specifically

https://www.targetmol.com/compound/emibetuzumab